Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1967 Apr;165(4):551–556. doi: 10.1097/00000658-196704000-00008

Problems in hemostasis during open heart urgery. VII. Changes in fibrinogen concentration during and after cardiopulmonary bypass with particular reference to the effect of heparin neutralization on fibrinogen.

H Gans, A R Castaneda
PMCID: PMC1617443  PMID: 6021455

Full text

PDF
551

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Castaneda A. R. Must heparin be neutralized following open-heart operations? J Thorac Cardiovasc Surg. 1966 Nov;52(5):716–724. [PubMed] [Google Scholar]
  2. DERECHIN M. Paracoagulación fibrinolätica: nuevo fenómeno vinculado a la fibrinolisis. Prensa Med Argent. 1953 Oct 9;40(41):2763–2764. [PubMed] [Google Scholar]
  3. DEWALL R., LILLEHEI C. W., HODGES P., LONG D., WADE J., CARDOZO R. DESCRIPTION OF THE HELICAL RESERVOIR BUBBLE-TYPE PUMP OXYGENATOR FOR HEMODILUTION HYPOTHERMIC PERFUSIONS. Dis Chest. 1963 Aug;44:113–120. doi: 10.1378/chest.44.2.113. [DOI] [PubMed] [Google Scholar]
  4. EGERTON W. S., ROBINSON C. L. The anti-heparin, anticoagulant and hypotensive properties of hexadimethrine and protamine. Lancet. 1961 Sep 16;2(7203):635–637. doi: 10.1016/s0140-6736(61)90311-7. [DOI] [PubMed] [Google Scholar]
  5. EIBER H. B., DANISHEFSKY I., BORRELLI F. J. Studies made with radioactive heparin in humans. Angiology. 1960 Feb;11:40–43. doi: 10.1177/000331976001100108. [DOI] [PubMed] [Google Scholar]
  6. Frick P. G., Brögli H. The mechansim of heparin rebound after extracorporeal circulation for open cardiac surgery. Surgery. 1966 May;59(5):721–726. [PubMed] [Google Scholar]
  7. GANS H., KRIVIT W. Problems in hemostasis during openheart surgery. IV. On the changes in the blood clotting mechanism during cardiopulmonary bypass procedures. Ann Surg. 1962 Mar;155:353–359. doi: 10.1097/00000658-196203000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gans H. Preservation of vascular patency as a function of reticuloendothelial clearance. Surgery. 1966 Dec;60(6):1216–1223. [PubMed] [Google Scholar]
  9. Gans H. Thrombogenic properties of epsilon amino caproic acid. Ann Surg. 1966 Feb;163(2):175–178. doi: 10.1097/00000658-196602000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. HOUGIE C. Anticoagulant action of protamine sulphate. Proc Soc Exp Biol Med. 1958 May;98(1):130–133. doi: 10.3181/00379727-98-23963. [DOI] [PubMed] [Google Scholar]
  11. KOWALSKI E. Fibrinogen derived inhibitors of blood coagulation. Thromb Diath Haemorrh. 1960;4(Suppl):211–223. [PubMed] [Google Scholar]
  12. NILSSON I. M., SWEDBERG J. Coagulation studies in cardiac surgery with extracorporeal circulation using a bubble-oxygenator. Acta Chir Scand. 1959 May 31;117(1-2):47–54. [PubMed] [Google Scholar]
  13. ZUHDI N., McCOLLOUGH B., CAREY J., GREER A. Double-belical reservoir heart-lung machine designed for hypothermic perfusion; primed with 5 per cent glucose in water; inducing hemodilution. Arch Surg. 1961 Feb;82:320–325. doi: 10.1001/archsurg.1961.01300080148015. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES